• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯甲状腺病中T淋巴细胞产生的B细胞生长因子增加:CD4+ CD29+细胞的可能作用。

Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.

作者信息

Goto Y, Itoh M, Ohta Y, Ogawa N, Goto Y, Ohashi H

机构信息

Department of Internal Medicine III, Hamamatsu University School of Medicine, Japan.

出版信息

Thyroid. 1997 Aug;7(4):567-73. doi: 10.1089/thy.1997.7.567.

DOI:10.1089/thy.1997.7.567
PMID:9292944
Abstract

The possible role of B-cell growth factor (BCGF) in the abnormal activation of B cells in Graves' disease was investigated by measuring the production of BCGF by, and analyzing lymphocyte subsets of, peripheral blood cells and thyroid infiltrates from 10 patients with Graves' disease and peripheral blood cells from 9 healthy controls. Medium from peripheral blood and intrathyroidal T cells cultured in the absence or presence of phytohemagglutinin (PHA) was subjected to a bioassay with a cell line, KS-3.F10, responsive only to BCGF. The percentages of activated (DR+CD4+ and DR+CD8+) T cells in the thyroid of Graves' patients were significantly higher than those in the peripheral blood of patients or controls, whereas the percentage of naive (CD4+CD45RA+) T cells was lower. The percentage of B (CD20+) cells in peripheral blood was increased in patients compared with controls. BCGF production by T cells from the thyroid or peripheral blood of Graves' patients, in the absence or presence of PHA, was significantly greater than that by peripheral T cells from healthy controls. PHA-stimulated BCGF production by peripheral T cells of Graves' patients showed a significant negative correlation with the percentage of DR+CD8+ cells in peripheral blood, whereas spontaneous and PHA-stimulated BCGF production by intrathyroidal T cells from Graves' patients showed a positive correlation with the serum concentrations of triiodothyronine (T3) or thyroxine (T4). The different distributions of CD4+ T-cell subsets between thyroid and peripheral blood suggest an important role for intrathyroidal helper/suppressor-inducer (CD4+CD29+) cells in the increased production of BCGF and consequent exacerbation of autoimmunity in Graves' disease.

摘要

通过检测10例格雷夫斯病患者外周血细胞和甲状腺浸润细胞以及9例健康对照者外周血细胞中B细胞生长因子(BCGF)的产生情况,并分析淋巴细胞亚群,研究了BCGF在格雷夫斯病B细胞异常激活中的可能作用。将外周血和甲状腺内T细胞在有无植物血凝素(PHA)的情况下培养,然后用仅对BCGF有反应的细胞系KS-3.F10进行生物测定。格雷夫斯病患者甲状腺中活化(DR + CD4 +和DR + CD8 +)T细胞的百分比显著高于患者外周血或对照者外周血中的百分比,而幼稚(CD4 + CD45RA +)T细胞的百分比则较低。与对照相比,患者外周血中B(CD20 +)细胞的百分比增加。在有无PHA的情况下,格雷夫斯病患者甲状腺或外周血T细胞产生的BCGF明显高于健康对照者外周血T细胞产生的BCGF。格雷夫斯病患者外周血T细胞经PHA刺激产生的BCGF与外周血中DR + CD8 +细胞的百分比呈显著负相关,而格雷夫斯病患者甲状腺内T细胞自发产生和经PHA刺激产生的BCGF与血清三碘甲状腺原氨酸(T3)或甲状腺素(T4)浓度呈正相关。甲状腺和外周血中CD4 + T细胞亚群的不同分布表明,甲状腺内辅助/抑制诱导(CD4 + CD29 +)细胞在格雷夫斯病中BCGF产生增加及自身免疫加剧过程中起重要作用。

相似文献

1
Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.格雷夫斯甲状腺病中T淋巴细胞产生的B细胞生长因子增加:CD4+ CD29+细胞的可能作用。
Thyroid. 1997 Aug;7(4):567-73. doi: 10.1089/thy.1997.7.567.
2
Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.格雷夫斯病患者甲状腺中抑制性T细胞功能障碍。
J Clin Endocrinol Metab. 1987 Nov;65(5):922-8. doi: 10.1210/jcem-65-5-922.
3
Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.免疫性和非免疫性甲状腺疾病患儿B(CD19)和T(CD3)淋巴细胞百分比、CD4、CD8亚群及其记忆(CD45RO)和初始(CD45RA)T细胞的变化分析
J Pediatr Endocrinol Metab. 2003 Jan;16(1):63-70. doi: 10.1515/jpem.2003.16.1.63.
4
Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.格雷夫斯病患者甲状腺组织中抑制诱导性T细胞亚群减少,辅助性T细胞亚群增加。
J Clin Endocrinol Metab. 1987 Jul;65(1):17-23. doi: 10.1210/jcem-65-1-17.
5
Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.格雷夫斯病患者甲状腺中浸润性T细胞上黏附分子的表达。
Clin Exp Immunol. 1993 Nov;94(2):363-70. doi: 10.1111/j.1365-2249.1993.tb03458.x.
6
Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease.格雷夫斯病患者甲状腺内淋巴细胞的表型分析及伴刀豆球蛋白A诱导的抑制细胞功能障碍
J Clin Endocrinol Metab. 1988 Nov;67(5):1018-24. doi: 10.1210/jcem-67-5-1018.
7
Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease.格雷夫斯病患者外周血和甲状腺组织中Ta1+细胞增加。
J Immunol. 1989 Jun 15;142(12):4233-40.
8
Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.格雷夫斯病和胰岛素依赖型糖尿病患者外周血中近期活化、记忆及初始淋巴细胞T亚群的分析。
Rocz Akad Med Bialymst. 1999;44:226-34.
9
Increased production of B cell growth factor (BCGF) in Sjögren's syndrome.干燥综合征中B细胞生长因子(BCGF)产生增加。
J Autoimmun. 1996 Aug;9(4):545-50. doi: 10.1006/jaut.1996.0073.
10
Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease.以三碘甲状腺原氨酸为主的格雷夫斯病中甲状腺上皮增生及胶体含量减少
J Clin Endocrinol Metab. 1992 Oct;75(4):1145-50. doi: 10.1210/jcem.75.4.1400885.

引用本文的文献

1
The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells.CD40和白细胞介素(IL-4)激活的CD23 +细胞对格雷夫斯病中单核细胞产生IL-10的影响:CD8 +细胞的作用
Clin Exp Immunol. 2002 May;128(2):308-12. doi: 10.1046/j.1365-2249.2002.01818.x.
2
Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).格雷夫斯病(GD)患者经CD40和IL-4激活的单核细胞中CD8和CD23可溶性形式的表面表达及释放
Clin Exp Immunol. 1998 Aug;113(2):309-14. doi: 10.1046/j.1365-2249.1998.00658.x.